Dow Jones

40 737,74

1,31%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
20/10/2020	14h00	PR Newswire (US)	Insmed to Host Third Quarter 2020 Financial Results Conference Call on Thursday, October 29, 2020	NASDAQ:INSM	Insmed Inc
02/10/2020	14h00	PR Newswire (US)	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:INSM	Insmed Inc
30/09/2020	14h00	PR Newswire (US)	Insmed Highlights Progress Across Portfolio and Outlines Growth Strategy at R&D Day	NASDAQ:INSM	Insmed Inc
16/09/2020	14h00	PR Newswire (US)	Insmed to Host R&D Day on September 30, 2020	NASDAQ:INSM	Insmed Inc
09/09/2020	22h05	PR Newswire (US)	Insmed to Present at Three September Conferences	NASDAQ:INSM	Insmed Inc
07/09/2020	17h24	PR Newswire (US)	New England Journal of Medicine Publishes Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cyst...	NASDAQ:INSM	Insmed Inc
13/08/2020	22h12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
06/08/2020	13h31	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INSM	Insmed Inc
06/08/2020	13h31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INSM	Insmed Inc
06/08/2020	13h30	PR Newswire (US)	Insmed Reports Second Quarter 2020 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
27/07/2020	14h00	PR Newswire (US)	Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020	NASDAQ:INSM	Insmed Inc
24/07/2020	13h39	PR Newswire (US)	Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infect...	NASDAQ:INSM	Insmed Inc
07/07/2020	14h00	PR Newswire (US)	New NTM Treatment Guidelines Recommend Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of Patient...	NASDAQ:INSM	Insmed Inc
24/06/2020	22h01	PR Newswire (US)	Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis Presented at AT...	NASDAQ:INSM	Insmed Inc
08/06/2020	14h00	PR Newswire (US)	Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCF...	NASDAQ:INSM	Insmed Inc
26/05/2020	14h00	PR Newswire (US)	Insmed to Present at Two June Conferences	NASDAQ:INSM	Insmed Inc
21/05/2020	22h10	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	NASDAQ:INSM	Insmed Inc
21/05/2020	22h08	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:INSM	Insmed Inc
20/05/2020	15h29	PR Newswire (US)	Insmed to Showcase New Brensocatib Data at American Thoracic Society Virtual Clinical Trials Session	NASDAQ:INSM	Insmed Inc
05/05/2020	23h30	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:INSM	Insmed Inc
05/05/2020	14h00	PR Newswire (US)	Insmed Announces Pricing of Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
04/05/2020	22h01	PR Newswire (US)	Insmed Announces Proposed Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
30/04/2020	13h30	PR Newswire (US)	Insmed Reports First Quarter 2020 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
23/04/2020	12h00	PR Newswire (US)	Brensocatib (Formerly INS1007) to be Studied in Patients with Severe COVID-19 in Investigator-Initiated Trial	NASDAQ:INSM	Insmed Inc
20/04/2020	14h00	PR Newswire (US)	Insmed to Host First Quarter 2020 Financial Results Conference Call on Thursday, April 30, 2020	NASDAQ:INSM	Insmed Inc
02/04/2020	23h46	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INSM	Insmed Inc
02/04/2020	14h00	PR Newswire (US)	Insmed Appoints Carol A. Schafer to its Board of Directors	NASDAQ:INSM	Insmed Inc
31/03/2020	15h06	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:INSM	Insmed Inc
31/03/2020	15h05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:INSM	Insmed Inc
27/03/2020	23h39	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:INSM	Insmed Inc